NEW YORK (GenomeWeb) – InformedDNA announced on Monday a collaboration with NIA Magellan to offer an evidence-based genetics benefits program.
As the number of commercially available genetic tests and the inappropriate use of such tests grow rapidly, the collaboration "provides a critical solution by offering genetic testing guidance by independent genetics specialists to patients and physicians alike," St. Petersburg, Fla.-based InformedDNA said in a statement.
The company has a national network of board-certified genetics specialists to provide clinical review services, ensuring appropriate use of genetics tests and delivering cost savings, it said. It will couple its services with NIA Magellan's solutions to deliver cost-effective and clinically actionable genetic testing, it added.
NIA Magellan is a division of healthcare management firm Magellan Health.
"[D]eploying InformedDNA's genetics expertise within NIA Magellan's established technology infrastructure allows InformedDNA to continue our rapid growth with health plan customers of all sizes," InformedDNA CEO David Nixon said.